Walleye Capital
KURA icon

Walleye Capital’s Kura Oncology KURA Stock Holding History

Walleye Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244K Buy
30,000
+18,500
+161% +$159K ﹤0.01% 3208
2025
Q4 		$119K Buy
+11,500
New +$121K ﹤0.01% 3802
2024
Q4 		– Sell
-8,500
Closed -$166K – 5215
2024
Q3 		$166K Sell
8,500
-3,600
-30% -$72.9K ﹤0.01% 4129
2024
Q2 		$249K Buy
12,100
+11,000
+1,000% +$226K ﹤0.01% 4136
2024
Q1 		$23.5K Buy
+1,100
New +$21.4K ﹤0.01% 4884

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's KURA Position: Q1 2026 in Review

Walleye Capital increased its Kura Oncology (KURA) stake by 5,811% in Q1 2026, buying an estimated $1.87M and bringing the position to 221,205 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #1553.

Walleye Capital first reported a position in KURA in Q3 2018 and has held it in 14 quarters since. The position peaked at $11.2M in Q3 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Walleye Capital held 221,205 shares of Kura Oncology worth $1.8M as of Q1 2026.
  • Walleye Capital bought 217,463 Kura Oncology shares in Q1 2026, an estimated $1.87M.
  • Kura Oncology made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1553 holding.
  • Walleye Capital first reported a position in Kura Oncology in Q3 2018 and has held it in 14 quarters since.
  • Walleye Capital's Kura Oncology position peaked at $11.2M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.